Flow cytometry: Prostate cancer cell lines stained with stemness markers (CD44, CD133, and CD44/133) to determine the percent of CD44+, CD133+, and double-positive cells in prostate cancer subtypes. This evidence concerns the gene PROM1 and Familial prostate cancer.